RankAlpha logo
Back to Rankings

NTRA

NateraB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Q2 results show sustained commercial acceleration, especially in oncology, alongside improving gross margin and a substantial guidance increase. Regulatory approvals, expanded Medicare coverage, and product enhancement support continued adoption [#SEC-8K-2026-08-06].
Posture
Constructive
Lead driver
Sentiment
What changed
3 setup hits (3d) with net bullish as of 2026-09-10.
What can break
Gross margin remains sensitive to revenue-accrual estimates and cost-of-revenue execution.
Momentum
87
Value
48
Sentiment
64
Setup hits (3d)
3 · Net Bullish
AI TargetsBase $335.00 · Bull $380.00 · Bear $270.00Analysis 2026-08-08; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-08 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-09-10

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions

Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Bullish
Target $344.33
Why
Momentum87 · Δ7d -6.8
Value48 · Δ7d -0.0
Sentiment64 · Δ7d +0.7
So what
Strength-led posture (Net Bullish). Favor watchlist adds and disciplined entries.

Confirming evidence

  • • 3 setup hits (3d) with net bullish as of 2026-09-10.
  • • Sentiment remains the lead driver in the composite, 7D delta +0.7.

Contradictions & invalidation

  • • Gross margin remains sensitive to revenue-accrual estimates and cost-of-revenue execution.
  • • Post-earnings momentum may reverse if future volume or oncology growth fails to sustain the current pace.
  • • The post-print rally may have discounted much of the guidance increase.

Catalyst clock

2026-08-06

Q2 2026 results and raised revenue outlook

Lead driver: Sentiment · See AI snapshot
Momentum
87
9% active weight
Current posture
7d trendSoftening
Δ7d
-6.8
Δ21d
-2.8
Value
48
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.0
Sentiment
64
62% active weight
Current posture
7d trendFlat
Δ7d
+0.7
Δ21d
-3.0
Why this grade

Composite grade B. Momentum 87.4 / Value 48.4 / Sentiment 63.6

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-08. Scenario method

B+
Bull case
25%
Probability
Target price
$380.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
Most likely
B
Base case
50%
Probability
Target price
$335.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$270.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$45.29B
Beta
1.63
Shares Out
144.14M
P/E (TTM) · Derived
-206.4
P/S (TTM)
15.61
P/FCF (TTM)
353.07
Rev YoY
+37.7%
EPS YoY
-36.8%
Gross Margin
+64.7%
Op Margin
-10.6%
Net Debt
-$861.76M
Current Ratio
3.00
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data